Cargando…

Extralymphatic virus sanctuaries as a consequence of potent T-cell activation

T helper cells can support the functions of CD8(+) T cells against persistently infecting viruses such as murine lymphocytic choriomeningitis virus (LCMV), cytomegalovirus, hepatitis C virus and HIV. These viruses often resist complete elimination and remain detectable at sanctuary sites, such as th...

Descripción completa

Detalles Bibliográficos
Autores principales: Recher, Mike, Lang, Karl S, Navarini, Alexander, Hunziker, Lukas, Lang, Philipp A, Fink, Katja, Freigang, Stefan, Georgiev, Panco, Hangartner, Lars, Zellweger, Raphael, Bergthaler, Andreas, Hegazy, Ahmed N, Eschli, Bruno, Theocharides, Alexandre, Jeker, Lukas T, Merkler, Doron, Odermatt, Bernhard, Hersberger, Martin, Hengartner, Hans, Zinkernagel, Rolf M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096094/
https://www.ncbi.nlm.nih.gov/pubmed/17982463
http://dx.doi.org/10.1038/nm1670
_version_ 1783510750651744256
author Recher, Mike
Lang, Karl S
Navarini, Alexander
Hunziker, Lukas
Lang, Philipp A
Fink, Katja
Freigang, Stefan
Georgiev, Panco
Hangartner, Lars
Zellweger, Raphael
Bergthaler, Andreas
Hegazy, Ahmed N
Eschli, Bruno
Theocharides, Alexandre
Jeker, Lukas T
Merkler, Doron
Odermatt, Bernhard
Hersberger, Martin
Hengartner, Hans
Zinkernagel, Rolf M
author_facet Recher, Mike
Lang, Karl S
Navarini, Alexander
Hunziker, Lukas
Lang, Philipp A
Fink, Katja
Freigang, Stefan
Georgiev, Panco
Hangartner, Lars
Zellweger, Raphael
Bergthaler, Andreas
Hegazy, Ahmed N
Eschli, Bruno
Theocharides, Alexandre
Jeker, Lukas T
Merkler, Doron
Odermatt, Bernhard
Hersberger, Martin
Hengartner, Hans
Zinkernagel, Rolf M
author_sort Recher, Mike
collection PubMed
description T helper cells can support the functions of CD8(+) T cells against persistently infecting viruses such as murine lymphocytic choriomeningitis virus (LCMV), cytomegalovirus, hepatitis C virus and HIV. These viruses often resist complete elimination and remain detectable at sanctuary sites, such as the kidneys and other extralymphatic organs. The mechanisms underlying this persistence are not well understood. Here we show that mice with potent virus-specific T-cell responses have reduced levels and delayed formation of neutralizing antibodies, and these mice fail to clear LCMV from extralymphatic epithelia. Transfer of virus-specific B cells but not virus-specific T cells augmented virus clearance from persistent sites. Virus elimination from the kidneys was associated with the formation of IgG deposits in the interstitial space, presumably from kidney-infiltrating B cells. CD8(+) T cells in the kidneys of mice that did not clear virus from this site were activated but showed evidence of exhaustion. Thus, we conclude that in this model of infection, site-specific virus persistence develops as a consequence of potent immune activation coupled with reductions in virus-specific neutralizing antibodies. Our results suggest that sanctuary-site formation depends both on organ anatomy and on the induction of different adaptive immune effector mechanisms. Boosting T-cell responses alone may not reduce virus persistence. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nm1670) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7096094
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-70960942020-03-26 Extralymphatic virus sanctuaries as a consequence of potent T-cell activation Recher, Mike Lang, Karl S Navarini, Alexander Hunziker, Lukas Lang, Philipp A Fink, Katja Freigang, Stefan Georgiev, Panco Hangartner, Lars Zellweger, Raphael Bergthaler, Andreas Hegazy, Ahmed N Eschli, Bruno Theocharides, Alexandre Jeker, Lukas T Merkler, Doron Odermatt, Bernhard Hersberger, Martin Hengartner, Hans Zinkernagel, Rolf M Nat Med Article T helper cells can support the functions of CD8(+) T cells against persistently infecting viruses such as murine lymphocytic choriomeningitis virus (LCMV), cytomegalovirus, hepatitis C virus and HIV. These viruses often resist complete elimination and remain detectable at sanctuary sites, such as the kidneys and other extralymphatic organs. The mechanisms underlying this persistence are not well understood. Here we show that mice with potent virus-specific T-cell responses have reduced levels and delayed formation of neutralizing antibodies, and these mice fail to clear LCMV from extralymphatic epithelia. Transfer of virus-specific B cells but not virus-specific T cells augmented virus clearance from persistent sites. Virus elimination from the kidneys was associated with the formation of IgG deposits in the interstitial space, presumably from kidney-infiltrating B cells. CD8(+) T cells in the kidneys of mice that did not clear virus from this site were activated but showed evidence of exhaustion. Thus, we conclude that in this model of infection, site-specific virus persistence develops as a consequence of potent immune activation coupled with reductions in virus-specific neutralizing antibodies. Our results suggest that sanctuary-site formation depends both on organ anatomy and on the induction of different adaptive immune effector mechanisms. Boosting T-cell responses alone may not reduce virus persistence. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nm1670) contains supplementary material, which is available to authorized users. Nature Publishing Group US 2007-11-04 2007 /pmc/articles/PMC7096094/ /pubmed/17982463 http://dx.doi.org/10.1038/nm1670 Text en © Nature Publishing Group 2007 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Recher, Mike
Lang, Karl S
Navarini, Alexander
Hunziker, Lukas
Lang, Philipp A
Fink, Katja
Freigang, Stefan
Georgiev, Panco
Hangartner, Lars
Zellweger, Raphael
Bergthaler, Andreas
Hegazy, Ahmed N
Eschli, Bruno
Theocharides, Alexandre
Jeker, Lukas T
Merkler, Doron
Odermatt, Bernhard
Hersberger, Martin
Hengartner, Hans
Zinkernagel, Rolf M
Extralymphatic virus sanctuaries as a consequence of potent T-cell activation
title Extralymphatic virus sanctuaries as a consequence of potent T-cell activation
title_full Extralymphatic virus sanctuaries as a consequence of potent T-cell activation
title_fullStr Extralymphatic virus sanctuaries as a consequence of potent T-cell activation
title_full_unstemmed Extralymphatic virus sanctuaries as a consequence of potent T-cell activation
title_short Extralymphatic virus sanctuaries as a consequence of potent T-cell activation
title_sort extralymphatic virus sanctuaries as a consequence of potent t-cell activation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096094/
https://www.ncbi.nlm.nih.gov/pubmed/17982463
http://dx.doi.org/10.1038/nm1670
work_keys_str_mv AT rechermike extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT langkarls extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT navarinialexander extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT hunzikerlukas extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT langphilippa extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT finkkatja extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT freigangstefan extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT georgievpanco extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT hangartnerlars extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT zellwegerraphael extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT bergthalerandreas extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT hegazyahmedn extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT eschlibruno extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT theocharidesalexandre extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT jekerlukast extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT merklerdoron extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT odermattbernhard extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT hersbergermartin extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT hengartnerhans extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation
AT zinkernagelrolfm extralymphaticvirussanctuariesasaconsequenceofpotenttcellactivation